Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT02611492
Title A Phase III Randomized Trial of the Reduction of Chemotherapy in Philadelphia Chromosome-positive ALL of Young Adults (GRAAPH2014)
Recruitment Recruiting
Gender both
Phase Phase III
Variant Requirements No
Sponsors Assistance Publique - Hopitaux de Paris
Indications

acute lymphoblastic leukemia

Therapies

Mercaptopurine + Methotrexate + Nilotinib

Cytarabine + Dexamethasone + Filgrastim + Methotrexate + Nilotinib + Vincristine Sulfate

Imatinib

Age Groups: adult | senior
Covered Countries FRA


No variant requirements are available.